2024-27
Our Research Strategy
We directly fund and encourage high quality research and innovation in MSK health
Our 2024-27 research strategy places a heavy focus on research projects most capable of delivering benefits to patients and the healthcare system in a relatively short time-span, either by creating new MSK solutions (innovative products and services) or improving clinical practices and processes.
During the past decade we have invested £13.59m on research projects that expand knowledge, improve patient outcomes and pioneer new forms of diagnosis and treatment, including the application of AI and digital technologies.
We can enable clinicians and scientists to support the millions of people suffering from poor bone, joint and muscle health by:
- Focusing our investments on research projects most capable of delivering benefits to patients and the healthcare system in a relatively short time-span.
- Partnering with leading academic institutions, healthcare organisations, societies, charities (primarily as part of ARMA) and private companies.
- Supporting the overall research eco-system, especially at a time when clinical research faces significant challenges.
- Helping to accelerate the translation of research ideas into new
products or services. - Working with others to encourage the development of a more equal, diverse and inclusive research culture, and make the case for increased investment in MSK conditions.
According to our CEO, Dr Arash Angadji, ‘Our strategy aims to support MSK researchers throughout their careers. This includes helping the more entrepreneurially-minded researchers translate their ideas into new products and services.’
Our research objectives
We fund MSK research in the areas of diagnosis and treatment to:
- Expand knowledge.
- Improve patient outcomes.
- Pioneer new forms of treatment.
- Improve support for patients.
- Ease the burden on the NHS.
- Develop our understanding of MSK conditions.
Our measures for success are:
- Increased awareness of our research among professionals and patients.
- The nurturing of talent within the field of MSK medicine.
- The recruitment of advocates for our research within the broader MSK community.
- Securing co-funding from partners for our research projects.
- Peer-reviewed publications of the results of our funded research
The results of research are generally readily available in the public domain through the publication of results in the media and the public presentation of research projects.
These presentations and publications are always peer reviewed to ensure a
consistently high quality of research.
Our Aim
We aim to reduce the burden of poor musculoskeletal (MSK) health on individuals, workplaces and our health system by providing training and education programmes for MSK professionals and by funding research projects and breakthrough innovations (in partnership with grant givers, leading academic institutions and entrepreneurs) that expand knowledge, improve patient outcomes and pioneer new forms of orthopaedic diagnosis and treatment.
